NEW YORK (GenomeWeb News) – Link Technologies has licensed Agilent Technologies' RNA monomers technology, the Scottish company said today.

Link Technologies said it will manufacture and sell the four RNA monomer phosphoramidite reagents for use in research.

The company makes reagents for oligonucleotide synthesis and modification, and it offers a variety of products including phosphoramidites, solid supports, modifiers, labels, bioconjugation and oligo-immobilisation products.

Financial terms of the agreement were not released.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

In PLOS this week: grey wolf population genomics, mutations associated with lung adenocarcinoma survival, and more.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.